Michihiro Hidaka, Koiti Inokuchi, Nobuhiko Uoshima, Naoto Takahashi, Nao Yoshida, Shuichi Ota, Hirohisa Nakamae, Hiromi Iwasaki, Kenichiro Watanabe, Yoshiyuki Kosaka, Norio Komatsu, Kuniaki Meguro, Yuho Najima, Tetsuya Eto, Takeshi Kondo, Shinya Kimura, Chikashi Yoshida, Yuichi Ishikawa, Masashi Sawa, Tomoko Hata, Keizo Horibe, Hiroatsu Iida, Takeshi Shimomura, Nobuaki Dobashi, Isamu Sugiura, Junya Makiyama, Naoyuki Miyagawa, Asuka Sato, Ryuta Ito, Itaru Matsumura, Yuzuru Kanakura, Tomoki Naoe
OBJECTIVE: Minimal residual disease assessment of BCR-ABL messenger ribonucleic acid levels is crucial in Philadelphia chromosome-positive acute lymphoblastic leukemia for prognosis and treatment planning. However, accurately quantifying minor BCR-ABL transcripts, which comprise 70% of Philadelphia chromosome-positive acute lymphoblastic leukemia cases, lacks a national-approved method. METHODS: We developed the "Otsuka" minor BCR-ABLmessenger ribonucleic acid assay kit with exceptional precision (0...
November 20, 2023: Japanese Journal of Clinical Oncology